Using novel Fn14 inhibitory antibodies to treat cardiac cachexia in cancer

Project Description

This project tests the therapeutic potential of novel antibodies for reducing the heart failure associated with many cancers and chemotherapeutics. The results will lead to better treatment approaches and improved health outcomes for cancer patients.

Year

2017-2019

Researchers

Dr Kate Murphy, Prof John Silke, Prof Gordon Lynch, Prof Leanne Delbridge

Funding Body

Cancer Council Research Grant

Institution

The University of Melbourne

Funding

$72,644 in 2017, $95,137 in 2018 and $95,137 in 2019

Updated: